RECOMBINATE ANTHIHAEMOPHILIC 1000 IU International Unit Pdr+Solv for Soln for Inj Ireland - English - HPRA (Health Products Regulatory Authority)

recombinate anthihaemophilic 1000 iu international unit pdr+solv for soln for inj

baxter healthcare limited - factor viii, human recombinant - pdr+solv for soln for inj - 1000 iu international unit

RECOMBINATE ANTIHAEMOPHILIC FACTOR 250 IU International Unit Pdr+Solv for Soln for Inj Ireland - English - HPRA (Health Products Regulatory Authority)

recombinate antihaemophilic factor 250 iu international unit pdr+solv for soln for inj

baxter healthcare limited - factor viii, human recombinant - pdr+solv for soln for inj - 250 iu international unit

RECOMBINATE ANTIHAEMOPHILIC FACTOR 500 IU International Unit Pdr+Solv for Soln for Inj Ireland - English - HPRA (Health Products Regulatory Authority)

recombinate antihaemophilic factor 500 iu international unit pdr+solv for soln for inj

baxter healthcare limited - factor viii, human recombinant - pdr+solv for soln for inj - 500 iu international unit

Recombinate 1000 IU, powder and solvent for solution for injection Ireland - English - HPRA (Health Products Regulatory Authority)

recombinate 1000 iu, powder and solvent for solution for injection

baxalta innovations gmbh - factor viii, human recombinant - powder and solvent for solution for injection - 1000 iu international unit(s) - blood coagulation factors; coagulation factor viii - antihaemorrhagics: blood coagulation factor viii - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency). this product does not contain von willebrand factor and is therefore not indicated in von willebrand’s disease